ARWR - Arrowhead Pharmaceuticals Inc.
IEX Last Trade
23.82
-0.260 -1.092%
Share volume: 1,230,224
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$24.08
-0.26
-1.08%
Summary score
10%
Profitability
0%
Dept financing
15%
Liquidity
75%
Performance
1%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.71%
Return on assets
-7.61%
Return on sales
-469.88%
Return on invested capital
-94.7%
Total debt ratio
41.42%
Debt ratio change over timeo
-1.67%
Current Ratio
5.18%
Quick Ratio
5.18%
Cash Position Ratio
4.87%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-44.34%
Return on assets
-15.52%
Return on sales
-1722.41%
Return on invested capital
-40.7%
Total debt ratio
60.61%
Debt ratio change over timeo
-2.51%
Current Ratio
5.68%
Quick Ratio
5.68%
Cash Position Ratio
5.44%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-25.9%
Return on assets
-13.21%
Return on sales
0%
Return on invested capital
-35.97%
Total debt ratio
49.35%
Debt ratio change over time
-2.21%
Current Ratio
8.31%
Quick Ratio
8.31%
Cash Position Ratio
8.03%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-46.94%
Return on assets
-74.33%
Return on sales
1343.53%
Return on invested capital
-2.06%
Total debt ratio
-167.47%
Debt ratio change over time
-1.67%
Current Ratio
-11.58%
Quick Ratio
-11.58%
Cash Position Ratio
-11.23%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ARWR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.71% | 15.05% | 35.64% | 7.13% |
| Return on assets | -7.61% | 2.88% | 3.13% | 5.53% |
| Return on sales | -469.88% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | -94.7% | 2.57% | 5.37% | 18.48% |
| Profitability | 0% | 45% | 66% | 80% |
| Total debt ratio | 41.42% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -1.67% | 326.95% | -8.44% | 1.18% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 5.68% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 5.68% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 5.44% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 10% | 21% | 53% |
| Short-term ratios | ARWR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -44.34% | 13.14% | 10.88% | 4.07% |
| Return on assets | -15.52% | 2.1% | 1.54% | 3.03% |
| Return on sales | -1722.41% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | -40.7% | 1.95% | 2.74% | 9.55% |
| Profitability | 0% | 65% | 56% | 83% |
| Total debt ratio | 60.61% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -2.51% | 51.04% | -101.54% | 1.43% |
| Dept financing | 16% | 50% | 25% | 7% |
| Current Ratio | 5.68% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 5.68% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 5.44% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 9% | 20% | 57% |